Application of Ralph E. Miegel and John J. Verbanc

404 F.2d 378, 56 C.C.P.A. 761
CourtCourt of Customs and Patent Appeals
DecidedDecember 5, 1968
DocketPatent Appeal 8011
StatusPublished
Cited by3 cases

This text of 404 F.2d 378 (Application of Ralph E. Miegel and John J. Verbanc) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Application of Ralph E. Miegel and John J. Verbanc, 404 F.2d 378, 56 C.C.P.A. 761 (ccpa 1968).

Opinions

ALMOND, Judge.

This is an appeal from the decision of the Board of Appeals affirming the rejection of claim 3, the only claim in appellants’ application.1

Appellants’ invention is a curable composition of butadiene-styrene copolymer and bis (2,6-dimethylmorpholinothio-carbonyl) monosulfide. The monosulfide acts as a vulcanization accelerator for the butadiene-styrene copolymer elastomer and is said to afford fast and effective cures of the butadiene-styrene rubber while exhibiting an exceptional degree of processing safety.

The claim on appeal reads as follows:

3. A composition exhibiting fast curing and improved processing safety comprising a butadiene-styrene co-polymer and from about 0.4 to about 1.5 parts by weight of bis (2,6-di-methylmorpholinothioearbonyl) mono-sulfide per one hundred parts of said copolymer.

The references are:

Naunton et al. 1,867,982 July 19,1932 (Naunton)
Whitby, G.S., Synthetic Rubber, John Wiley and Sons, Inc., New York 1954, p. 392 (Whitby)

[380]*380Naunton discloses that morpholine thiuram monosulfides and polysulfides, as well as homologs and derivatives of morpholine, are “safe” super-accelerators for rubber. The patentee states that the homologs and derivatives of morpholine as well as morpholine itself may be prepared in the manner described in the reference patent to Payman.

Payman discloses a method for the manufacture of morpholine, its homologs and derivatives and specifically discloses the preparation of 2,6-dimethyl-morpholine. Payman further states that in the reference patent to Naunton there are disclosed processes for converting these morpholine compounds into other compounds which are useful in processes of vulcanizing rubber.

Whitby states that thiuram mono-sulfides and thiuram polysulfides are very good accelerators for GR-S2 and can be used in GR-S with less danger of scorching than in natural rubber.

The issue here is obviousness under 35 U.S.C. § 103.

The examiner rejected the claim as unpatentable over Naunton in view of Payman and Whitby. Noting that Naunton, with specific reference to Pay-man, teaches that homologs and derivatives of morpholine thiuram mono-sulfides “are accelerators for rubber which do not exhibit the tendency to induce scorching as well as having the capacity to activate a rapid cure” and that Payman specifically discloses 2,6-dimethylmorpholine as a precursor for the thiuram monosulfides, the examiner considered it obvious to convert the precursor to the thiuram monosulfide of the claim “using the same well-known procedures disclosed both by the primary reference and by appellants, to produce a compound which is used to impart fast curing and improved processing safety.” Stating that the two reference patents “are directed towards the preparation of vulcanization accelerators” for natural rubber, the examiner further considered it obvious to employ the claimed monosulfide as an accelerator for butadiene-styrene copolymer (GR-S rubber) in view of the teaching by Whit-by that the general class of thiuram monosulfides are good accelerators having less danger of scorching in GR-S rubber than in natural rubber.

The board, in affirming the rejection, added that since Payman “describes no other specific homolog of morpholine than 2,6-dimethylmorpholine, it would appear that this intermediate was offered as the preferred, or prototype, intermediate for the accelerator.”

We agree with the examiner and the board that it would be obvious to convert the 2,6-dimethylmorpholine precursor of Payman to the monosulfide of the claim and employ the monosulfide as an accelerator in composition with butadiene-styrene copolymer in view of Naunton’s explicit reference to Payman as a source of morpholine compounds for vulcanization accelerators and Whitby’s clear teaching that thiuram monosulfides are good accelerators for butadienestyrene copolymer. It is noted that the appellants urge no patentable distinction or critical significance in the claimed proportions.

Appellants argue, however, that their invention is patentable because of unexpectedly improved curing results obtained by their composition. In support of this argument, appellants direct our attention to two Rule 132 affidavits in [381]*381the record. While the examiner did not disagree with the affidavits’ showing, he felt that relative processing safety of the compared accelerators would be expected and any differences to be differences of degree only.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Application of Ellen L. Mochel
424 F.2d 620 (Customs and Patent Appeals, 1970)
Application of Alan J. Lemin, Arnolds Steinhards and George Swank
408 F.2d 1045 (Customs and Patent Appeals, 1969)
Application of Ralph E. Miegel and John J. Verbanc
404 F.2d 378 (Customs and Patent Appeals, 1968)

Cite This Page — Counsel Stack

Bluebook (online)
404 F.2d 378, 56 C.C.P.A. 761, Counsel Stack Legal Research, https://law.counselstack.com/opinion/application-of-ralph-e-miegel-and-john-j-verbanc-ccpa-1968.